RedHill Biopharma reported $-4.41M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.





Equity Capital And Reserves Change Date
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 43.83M 6.43M Sep/2025
Cronos Group USD 1.08B 214K Sep/2025
RedHill Biopharma USD -4.41M 271K Jun/2025